Identification |
Name: | Estra-1,3,5(10)-trien-17-one,3-(sulfooxy)-, sodium salt (1:1) |
Synonyms: | Estra-1,3,5(10)-trien-17-one,3-(sulfooxy)-, sodium salt (9CI); Estrone sulfate sodium salt (6CI); Estrone,hydrogen sulfate sodium salt (7CI,8CI); 3-Sulfatoxyestra-1,3,5(10)-trien-17-onesodium salt; Conestoral; Estrone sodium sulfate; Estrone sulfate sodium;Morestin; NSC 18313; Sodium estrone sulfate; Sodium estrone-3-sulfate |
CAS: | 438-67-5 |
EINECS: | 207-575-9 |
Molecular Formula: | C18H22 O5 S . Na |
Molecular Weight: | 372.41111 |
InChI: | InChI=1S/C18H22O5S.Na/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19;/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22);/q;+1/p-1/t14-,15-,16+,18+;/m1./s1 |
Molecular Structure: |
|
Properties |
Melting Point: | 173 ºC |
Density: | 1.349 g/cm3 |
Water Solubility: | 4.49e-03 mg/mL in water |
Solubility: | 4.49e-03 mg/mL in water |
Specification: | Off-White Solid usageEng:Estrogen used in hormone replacement therapy Safety Statements:53-45 53:Avoid exposure - obtain special instruction before use 45:In case of accident or if you feel unwell, seek medical
advice immediately (show label where possible) |
Report: |
NTP 10th Report on Carcinogens.
|
Storage Temperature: | −20°C |
Usage: |
Estrone sodium sulfate (438-67-5) is mainly used in hormone replacement therapy.
|
Safety Data |
Hazard Symbols |
T: Toxic
|
|
|